Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GUMM - Eliminate the Common Cold -- Ignore unavailable to you. Want to Upgrade?

To: DanZ who wrote (2644)	10/17/2000 9:39:34 PM
From: Hank	Read Replies (2) \| Respond to of 5582

The bottom line is that journal articles do not sell drugs, whether they be prescription or OTC. Advertising and sales do. PERIOD. As for my financial analysis ability, I have stated that GUMM has NEVER registered a profitable year to date. In fact, they have only shown ONE profitable quarter EVER. That's a FACT. Given the FACT that they are solidly in the red AGAIN so far this year to date, it is safe to say that they will not show a profit this year either. If in fact they actually undergo a serious advertising campaign for their products (which, so far, has been pathetic), the costs of doing so will bury them for the foreseeable future as they attempt to gain market share from better established and better funded competitors. Hence, it is a given they will lose money for next year as well. That's common sense math that even a third grader could understand. But then, I'm sure that you will spin each losing quarter in your own special way. After all, that's what you get paid for.